Inventiva Sa (IVA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.55
• Market Cap: $557.31M
• EPS: $-4.36
• 52-Week High: $7.98
• 52-Week Low: $2.67

Market Sentiment

Inventiva Sa currently has a Bullish sentiment score of 0.25.

About Inventiva Sa

Inventiva SA (IVA) is a clinical-stage biopharmaceutical firm based in Daix, France, focused on pioneering oral small molecule therapies for high unmet medical conditions, notably non-alcoholic steatohepatitis (NASH) and mucopolysaccharidosis (MPS). With a strong pipeline of proprietary drug candidates, the company is dedicated to tackling complex metabolic and rare diseases, positioning itself as a significant contributor to advancements in the biopharmaceutical industry. As it progresses to...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Inventiva Sa and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IVA pay dividends?

Inventiva Sa (IVA) does not currently pay a regular dividend.

What is IVA's market cap?

Inventiva Sa (IVA) has a market capitalization of $557.31M with a current stock price of $6.55.